APA (7th ed.) Citation

Patil, V. M., Bhosale, B. B., Noronha, V., & Prabhash, K. (2024). Phase 3 randomized study for evaluation of physician choice Rx versus best supportive care as second-line or beyond therapy in head and neck cancer with poor performance status. Journal of clinical oncology, 42(17_suppl), LBA6019. https://doi.org/10.1200/JCO.2024.42.17_suppl.LBA6019

Chicago Style (17th ed.) Citation

Patil, Vijay Maruti, Bharatsinha Baburao Bhosale, Vanita Noronha, and Kumar Prabhash. "Phase 3 Randomized Study for Evaluation of Physician Choice Rx Versus Best Supportive Care as Second-line or Beyond Therapy in Head and Neck Cancer with Poor Performance Status." Journal of Clinical Oncology 42, no. 17_suppl (2024): LBA6019. https://doi.org/10.1200/JCO.2024.42.17_suppl.LBA6019.

MLA (9th ed.) Citation

Patil, Vijay Maruti, et al. "Phase 3 Randomized Study for Evaluation of Physician Choice Rx Versus Best Supportive Care as Second-line or Beyond Therapy in Head and Neck Cancer with Poor Performance Status." Journal of Clinical Oncology, vol. 42, no. 17_suppl, 2024, p. LBA6019, https://doi.org/10.1200/JCO.2024.42.17_suppl.LBA6019.